Effects and side effects of long term steroid therapy of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis

F. Brinkmann, S. Junge, M. Ballmann (Germany)

Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Session: Cystic fibrosis: lung disease infection and more
Session type: E-Communication Session
Number: 3496
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Brinkmann, S. Junge, M. Ballmann (Germany). Effects and side effects of long term steroid therapy of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis. Eur Respir J 2010; 36: Suppl. 54, 3496

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Long term follow up of the lung function in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis
Source: Eur Respir J, 56 (2) 2000175; 10.1183/13993003.00175-2020
Year: 2020



Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 237s
Year: 2003

Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2003 Oct 01;22(4):592-595
Year: 2003



Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2014; 43: 1487-1500
Year: 2014



Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease?
Source: Eur Respir Rev 2010 19: 261-263
Year: 2010


Allergic bronchopulmonary aspergillosis in cystic fibrosis
Source: Eur Respir J 2001; 17: 156
Year: 2001


Allergic bronchopulmonary aspergillosis in cystic fibrosis
Source: Annual Congress 2009 - Update on eosinophilic lung diseases
Year: 2009


Allergic bronchopulmonary aspergillosis in cystic fibrosis
Source: Eur Respir J 2001; 17: 1052-1053
Year: 2001


Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015

Risk factors for allergic bronchopulmonary aspergillosis in paediatric patients with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010

The efficacity of omaluzimab in a case series with allergic bronchopulmonary aspergillosis and cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015


Vitamin D level in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and aspergillus sensitization
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016

Effect of itraconazole therapy on disease course in 3 cases of allergic bronchopulmonary mycosis presented as refractory asthma
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008

Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy
Source: Eur Respir J 2005; 25: 324-328
Year: 2005



Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis
Source: Eur Respir Rev 2010 19: 349-351
Year: 2010


Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA).
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide
Source: Eur Respir J 2002; 20: 127-133
Year: 2002